← Eichor
Study identifier: NCT03647072 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Condition: Lymphoma  ·  Sponsor: Sherief Abd-Elsalam

PhasePhase 3
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.

This description comes directly from the study's public registry record.

Talk to the study team

Sherief Abd-Elsalam, MD  ·  00201147773440  ·  sheriefabdelsalam@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sherief Abd-ElsalamCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03647072